Articles From: Celldex Therapeutics Announces Senior Leadership Promotions to Aegerion Pharmaceuticals Appoints Craig Fraser as Chief Operating Officer


HAMPTON, N.J., July 30, 2014 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) today announced three promotions in the Company's clinical and research departments: "We continue to build an exceptional team of senior leaders at Celldex who are committed to advancing our pipeline and improving the lives of patients facing cancer," said Anthony Marucci, President and Chief Executive Officer of Celldex.
Sign-up for Celldex Therapeutics Announces Senior Leadership Promotions investment picks
Company's 2013 " Committed to More " Sustainability Report Highlights Energy, Efficiency and Humanitarian Achievements More Commitment to Transparency by Becoming One of First U.S. Companies to Adopt New Comprehensive Level of Sustainability Reporting More Reductions as absolute carbon emissions decrease 1.5% More Lower-Emission Vehicles Hitting the Road as fleet logged 55 million miles and avoided the use of 5.8 million gallons of conventional gasoline and diesel More than 1.5M gallons of fuel saved annually through ORION Route Optimization More Sustainable Supply Chain Options for Customers like carbon neutral shipping for packages, documents, cargo or freight to anywhere in world More Resilient Global Communities through Humanitarian Aid as UPS enabled 250 humanitarian shipments across 46 countries ATLANTA, July 30, 2014 (GLOBE NEWSWIRE) -- UPS ® (NYSE:UPS) today released its 12 th annual Sustainability
Sign-up for UPS Doubles Carbon Intensity Goal for 2020 investment picks
Baxter International Inc. (NYSE:BAX) today announced that it has entered into a definitive agreement to sell its two commercially marketed vaccines and related production facilities to Pfizer Inc. for a total cash consideration of $635 million, subject to certain adjustments.
Sign-up for Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer investment picks
First Interactive Music App of its Kind for the Android Platform SCOTTSDALE, Ariz.
Sign-up for Beamz Interactive, Inc. Announces New Android App investment picks
Debtless College Education Solution Gaining Momentum NEW YORK, July 30, 2014 (GLOBE NEWSWIRE) -- Aspen Group, Inc. (OTCBB:ASPU) , a nationally accredited online post-secondary education company (Aspen University), today announced results for its fiscal 2014 fourth quarter ended April 30, 2014.
Sign-up for Aspen Group Announces Increase in Revenue of 28% and Adjusted Gross Profit Increase of 76% for Fiscal 2014 Fourth Quarter investment picks
Youngevity International, Inc. (OTCQX: YGYI) ( www.YGYI.com ), announced today that it will host a conference call on Wednesday, August 13, 2014 at 4:15 PM Eastern Time (1:15 PM PST), to discuss the Company’s second quarter 2014 financial results, which it plans to release after the close of the market on the same date.
Sign-up for Youngevity International, Inc. (YGYI) to Host Second Quarter 2014 Earnings Conference Call investment picks
Synta Pharmaceuticals Corp.
Sign-up for Synta to Host Conference Call and Webcast of Second Quarter 2014 Financial Results on August 6, 2014 investment picks
Rayonier Advanced Materials Inc. (NYSE:RYAM) today reported financial results for the second quarter of 2014.
Sign-up for Rayonier Advanced Materials Reports Second Quarter Results investment picks
Speedway Motorsports, Inc. (SMI) (NYSE: TRK) today reported second quarter 2014 total revenues of $175.9 million, adjusted non-GAAP net income of $27.3 million or $0.66 per diluted share, and GAAP net income of $27.2 million or $0.66 per diluted share.
Sign-up for Speedway Motorsports Reports Results for the Three and Six Months Ended June 30, 2014 and Reaffirms Full Year 2014 Guidance investment picks
WOODCLIFF LAKE, N.J. and SAN DIEGO , July 30, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that an article based on post-hoc analyses from the three pivotal Phase 3 trials of lorcaserin entitled, "Early Weight Loss While on Lorcaserin, Diet, and Exercise as a Predictor of Week 52 Weight-Loss Outcomes," was recently published in the online issue of Obesity , the official peer reviewed journal of The Obesity Society.
Sign-up for Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity investment picks
SAN RAMON, Calif., July 30, 2014 (GLOBE NEWSWIRE) -- Five9 (Nasdaq:FIVN) , a leading provider of cloud contact center software, today announced it will host a live webinar on August 7, 2014 at 1:00 p.m. EDT on how The Shipyard uses its contact center to effectively run nationwide, multi-channel demand generation and nurture programs for its customers.
Sign-up for Five9 Presents Live Webinar on Driving Customer Demand With a Cloud Contact Center investment picks
OKLAHOMA CITY, July 30, 2014 (GLOBE NEWSWIRE) -- Gulfport Energy Corporation (Nasdaq:GPOR) ("Gulfport") today provides an update on its midstream activities in the Utica Shale of Eastern Ohio, announces second quarter 2014 production and schedules second quarter 2014 financial and operational results conference call.
Sign-up for Gulfport Energy Corporation Provides Midstream Update, Reports Second Quarter 2014 Production and Schedules Second Quarter 2014 Financial and Operational Results Conference Call investment picks
HOUSTON , July 30, 2014 /PRNewswire/ -- Omega Protein Corporation (NYSE: OME) , a nutritional product company and a leading integrated producer of omega-3 fish oil and specialty protein products, today announced Bret Scholtes , the Company's President & Chief Executive Officer, and Andrew Johannesen , Executive Vice President & Chief Financial Officer, will present at the Canaccord Genuity 34 th Annual Growth Conference on Wednesday, August 13, 2014 at 3:00 p.m. ET in Boston, MA.
Sign-up for Omega Protein To Present At The Canaccord Genuity 34th Annual Growth Conference investment picks
USMD Holdings, Inc. ( NASDAQ: USMD ), a physician-led integrated health system, announced today that USMD Hospital at Arlington has received a Healthgrades 2014 Patient Safety Excellence Award for their exceptional performance in safeguarding patients against serious and potentially preventable complications, such as infections, during their hospital stays.
Sign-up for USMD Hospital at Arlington Earns Healthgrades Patient Safety Excellence Award investment picks
Phillips 66 (NYSE: PSX), an energy manufacturing and logistics company, announced second-quarter earnings of $863 million, compared with first quarter of 2014 earnings of $1,572 million and adjusted earnings of $866 million.
Sign-up for Phillips 66 Reports Second-Quarter Earnings of $863 Million or $1.51 Per Share investment picks
Net Patient Service Revenue Increase of 80.6% Patient Volumes Up 70.9% Six New Facilities Opened for a total of 38 Freestanding Facilities LEWISVILLE, Texas , July 30, 2014 /PRNewswire/ -- Adeptus Health Inc. (NYSE: ADPT) ("ADPT" or the "Company") announced its results for the second quarter ended June 30, 2014 .
Sign-up for Adeptus Health Reports Second Quarter Results investment picks
For the fifth time, Aruba Networks, Inc. (NASDAQ:ARUN) has been named the official wireless network provider at Black Hat USA .
Sign-up for MEDIA ALERT: Aruba Networks To Provide Gigabit Wi-Fi Network for Black Hat USA 2014 investment picks
BEIJING, July 30, 2014 (GLOBE NEWSWIRE) -- ChinaCache International Holdings Ltd.
Sign-up for ChinaCache Appoints Former Verizon and Nielsen Executives to Lead Worldwide Growth Initiatives investment picks
ALBUQUERQUE, N.M., July 30, 2014 (GLOBE NEWSWIRE) -- EMCORE Corporation (Nasdaq:EMKR) , a leading provider of compound semiconductor-based components and subsystems for the fiber optics and space solar power markets, announced today that it has entered into a new, long-term supply agreement with Lockheed Martin Space Systems to design and manufacture high-efficiency, multi-junction Coverglass Interconnected Cells (CICs) for Lockheed Martin's satellite program requirements.
Sign-up for EMCORE Corporation Awarded Long-Term Supply Contract by Lockheed Martin investment picks
SAN DIEGO , July 30, 2014 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced it has received the Day 180 List of Outstanding Issues (LOI) from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for the NB32 Marketing Authorization Application (MAA). NB32 (naltrexone sustained release (SR) / bupropion SR) is an investigational drug candidate being evaluated for weight loss.
Sign-up for Orexigen Receives CHMP Day 180 List of Outstanding Issues investment picks
LAS VEGAS , July 30, 2014 /PRNewswire/ - LiveDeal Inc. (NASDAQ:LIVE) ("LiveDeal" or the "Company"), a publicly traded company that operates livedeal.com, a geo-location based mobile marketing platform that enables restaurants to publish "real-time" and "instant offers" to nearby consumers, today announces that it experienced a 277 percent spike in Android app downloads, compared to the prior week, which is due, in part, to the expansion of its ad campaign to 50 cities.
Sign-up for LiveDeal Inc. 50-City Ad Campaign Results in Nearly 300 Percent Spike in Android App Downloads investment picks
- Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor - PARIS and TARRYTOWN, N.Y. , July 30, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to placebo or active comparator.
Sign-up for Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia investment picks
Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor TARRYTOWN, N.Y. and PARIS , July 30, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to placebo or active comparator.
Sign-up for Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia investment picks
Weight-Management and Healthy Living Company Introduces New Line of Sleep Products OWINGS MILLS, Md.
Sign-up for Take Shape For Life Launches Habits of Healthy Sleep Set investment picks
SAN ANTONIO , July 30, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces the issuance of a United States patent entitled "Methods and compositions for the detection of cancer". The patent US 8,772,226 B2 was issued July 8, 2014 .
Sign-up for GenSpera Announces US Patent for Methods and Compositions for the Detection, Imaging and Treatment of Cancer investment picks
Harvest Capital Credit Corporation (NASDAQ: HCAP ), announced today that it will report financial results for the fiscal quarter ended June 30, 2014 before market open on Wednesday, August 13, 2014.
Sign-up for Harvest Capital Credit Corporation to Report Second Quarter 2014 Results on August 13, 2014 investment picks
PHOENIX, July 30, 2014 (GLOBE NEWSWIRE) -- Inventure Foods, Inc. (Nasdaq:SNAK) , a leading specialty food marketer and manufacturer, today announced that Terry McDaniel, President and CEO, and Steve Weinberger, CFO, will present at the Canaccord Genuity 34 th Annual Growth Conference on Wednesday, August 13, 2014 at 9:00 a.m. ET.
Sign-up for Inventure Foods to Present at the Canaccord Genuity 34th Annual Growth Conference investment picks
LONG BEACH, N.Y., July 30, 2014 (GLOBE NEWSWIRE) -- Planet Payment, Inc. (Nasdaq:PLPM) (LSE:PPT) , a leading provider of international payment and transaction processing and multi-currency processing services, today announced that it will host a conference call to discuss second quarter 2014 financial results on Monday, August 11, 2014 at 5:00pm New York time.
Sign-up for Planet Payment to Announce Second Quarter 2014 Results on August 11, 2014 investment picks
SOUTH PLAINFIELD, N.J. , July 30, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the Wedbush Life Sciences Management Access Conference on Tuesday, August 12th at 4:15 pm ET at the Le Parker Meridien in New York City .
Sign-up for PTC Therapeutics to Present at the Wedbush Life Sciences Management Access Conference investment picks
CAMBRIDGE, Mass., July 30, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) , a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, today announced that Craig Fraser has been appointed as Chief Operating Officer (COO). Prior to his appointment as COO, Mr.
Sign-up for Aegerion Pharmaceuticals Appoints Craig Fraser as Chief Operating Officer investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Celldex Therapeutics Announces Senior Leadership Promotions to Aegerion Pharmaceuticals Appoints Craig Fraser as Chief Operating Officer
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices